Neuromuscular Blocking Agents
"Neuromuscular Blocking Agents" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Drugs that interrupt transmission of nerve impulses at the skeletal neuromuscular junction. They can be of two types, competitive, stabilizing blockers (NEUROMUSCULAR NONDEPOLARIZING AGENTS) or noncompetitive, depolarizing agents (NEUROMUSCULAR DEPOLARIZING AGENTS). Both prevent acetylcholine from triggering the muscle contraction and they are used as anesthesia adjuvants, as relaxants during electroshock, in convulsive states, etc.
| Descriptor ID |
D009466
|
| MeSH Number(s) |
D27.505.696.663.700.710
|
| Concept/Terms |
Neuromuscular Blocking Agents- Neuromuscular Blocking Agents
- Agents, Neuromuscular Blocking
- Blocking Agents, Neuromuscular
- Neuromuscular Blockers
- Blockers, Neuromuscular
|
Below are MeSH descriptors whose meaning is more general than "Neuromuscular Blocking Agents".
Below are MeSH descriptors whose meaning is more specific than "Neuromuscular Blocking Agents".
This graph shows the total number of publications written about "Neuromuscular Blocking Agents" by people in this website by year, and whether "Neuromuscular Blocking Agents" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2016 | 1 | 0 | 1 |
| 2017 | 5 | 2 | 7 |
| 2018 | 4 | 1 | 5 |
| 2019 | 4 | 5 | 9 |
| 2020 | 3 | 3 | 6 |
| 2021 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Neuromuscular Blocking Agents" by people in Profiles.
-
Association of Sedation, Coma, and In-Hospital Mortality in Mechanically Ventilated Patients With Coronavirus Disease 2019-Related Acute Respiratory Distress Syndrome: A Retrospective Cohort Study. Crit Care Med. 2021 09 01; 49(9):1524-1534.
-
Cisatracurium-Associated Malignant Hyperthermia During Severe Sars-CoV-2 Infection. Am J Ther. 2021 08 10; 28(5):e590-e591.
-
Assessment of narcotic, sedative, and neuromuscular blocker needs of patients with COVID-19 requiring invasive mechanical ventilation. Am J Health Syst Pharm. 2021 06 23; 78(13):1168-1170.
-
Practice, Outcomes, and Complications of Emergent Endotracheal Intubation by Critical Care Practitioners During the COVID-19 Pandemic. Chest. 2021 12; 160(6):2112-2122.
-
Neuromuscular monitoring and neuromuscular blocking agent shortages when treating critically ill COVID-19 patients: a multicentre retrospective analysis. Br J Anaesth. 2021 08; 127(2):e73-e75.
-
Neuromuscular blockade management in patients with COVID-19. Korean J Anesthesiol. 2021 08; 74(4):285-292.
-
Recovery after critical illness in COVID-19 ICU survivors. Br J Anaesth. 2021 06; 126(6):e217-e219.
-
Sedation during mechanical ventilation of COVID-19 patients in intensive care units into operating rooms. Braz J Anesthesiol. 2021 Jan-Feb; 71(1):91-92.
-
Sedation, Analgesia, and Paralysis in COVID-19 Patients in the Setting of Drug Shortages. J Intensive Care Med. 2021 Feb; 36(2):157-174.
-
Neuromuscular blocking agents (NMBA) for COVID-19 acute respiratory distress syndrome: a multicenter observational study. Crit Care. 2020 07 19; 24(1):446.